294 related articles for article (PubMed ID: 33480803)
1. Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia.
Campbell-Salome G; Jones LK; Masnick MF; Walton NA; Ahmed CD; Buchanan AH; Brangan A; Esplin ED; Kann DG; Ladd IG; Kelly MA; Kindt I; Kirchner HL; McGowan MP; McMinn MN; Morales A; Myers KD; Oetjens MT; Rahm AK; Schmidlen TJ; Sheldon A; Simmons E; Snir M; Strande NT; Walters NL; Wilemon K; Williams MS; Gidding SS; Sturm AC
Circ Genom Precis Med; 2021 Feb; 14(1):e003120. PubMed ID: 33480803
[TBL] [Abstract][Full Text] [Related]
2. Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.
Sturm AC; Knowles JW; Gidding SS; Ahmad ZS; Ahmed CD; Ballantyne CM; Baum SJ; Bourbon M; Carrié A; Cuchel M; de Ferranti SD; Defesche JC; Freiberger T; Hershberger RE; Hovingh GK; Karayan L; Kastelein JJP; Kindt I; Lane SR; Leigh SE; Linton MF; Mata P; Neal WA; Nordestgaard BG; Santos RD; Harada-Shiba M; Sijbrands EJ; Stitziel NO; Yamashita S; Wilemon KA; Ledbetter DH; Rader DJ;
J Am Coll Cardiol; 2018 Aug; 72(6):662-680. PubMed ID: 30071997
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
[TBL] [Abstract][Full Text] [Related]
4. Improving the Detection of Potential Cases of Familial Hypercholesterolemia: Could Machine Learning Be Part of the Solution?
Stevens CAT; Vallejo-Vaz AJ; Chora JR; Barkas F; Brandts J; Mahani A; Abar L; Sharabiani MTA; Ray KK
J Am Heart Assoc; 2024 Jun; 13(12):e034434. PubMed ID: 38879446
[TBL] [Abstract][Full Text] [Related]
5. Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales.
Crosland P; Maconachie R; Buckner S; McGuire H; Humphries SE; Qureshi N
Atherosclerosis; 2018 Aug; 275():80-87. PubMed ID: 29879685
[TBL] [Abstract][Full Text] [Related]
6. Enhanced identification of familial hypercholesterolemia using central laboratory algorithms.
Ibrahim S; Nurmohamed NS; Nierman MC; de Goeij JN; Zuurbier L; van Rooij J; Schonck WAM; de Vries J; Hovingh GK; Reeskamp LF; Stroes ESG
Atherosclerosis; 2024 Jun; 393():117548. PubMed ID: 38643673
[TBL] [Abstract][Full Text] [Related]
7. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
[TBL] [Abstract][Full Text] [Related]
8. Detecting familial hypercholesterolemia earlier in life by actively searching for affected children:The DECOPIN project.
Ibarretxe D; Rodríguez-Borjabad C; Feliu A; Bilbao JÁ; Masana L; Plana N
Atherosclerosis; 2018 Nov; 278():210-216. PubMed ID: 30312929
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of mutations of familial hypercholesterolemia in the 22 Arab countries.
Alhababi D; Zayed H
Atherosclerosis; 2018 Dec; 279():62-72. PubMed ID: 30415195
[TBL] [Abstract][Full Text] [Related]
11. Genetic testing of familial hypercholesterolemia in a real clinical setting.
Vohnout B; Gabcova D; Huckova M; Klimes I; Gasperikova D; Raslova K
Wien Klin Wochenschr; 2016 Dec; 128(23-24):916-921. PubMed ID: 27542166
[TBL] [Abstract][Full Text] [Related]
12. Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations.
Martin R; Latten M; Hart P; Murray H; Bailie DA; Crockard M; Lamont J; Fitzgerald P; Graham CA
Atherosclerosis; 2016 Nov; 254():8-13. PubMed ID: 27680772
[TBL] [Abstract][Full Text] [Related]
13. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.
Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H
Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288
[TBL] [Abstract][Full Text] [Related]
14. Shortcomings on genetic testing of Familial hypercholesterolemia (FH) in India: Can we collaborate to establish Indian FH registry?
Reddy LL; Shah SAV; Ashavaid TF
Indian Heart J; 2022; 74(1):1-6. PubMed ID: 34875256
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
[TBL] [Abstract][Full Text] [Related]
16. Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis.
Chora JR; Medeiros AM; Alves AC; Bourbon M
Genet Med; 2018 Jun; 20(6):591-598. PubMed ID: 29261184
[TBL] [Abstract][Full Text] [Related]
17. Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia.
Alver M; Palover M; Saar A; Läll K; Zekavat SM; Tõnisson N; Leitsalu L; Reigo A; Nikopensius T; Ainla T; Kals M; Mägi R; Gabriel SB; Eha J; Lander ES; Irs A; Philippakis A; Marandi T; Natarajan P; Metspalu A; Kathiresan S; Esko T
Genet Med; 2019 May; 21(5):1173-1180. PubMed ID: 30270359
[TBL] [Abstract][Full Text] [Related]
18. A pragmatic clinical trial of cascade testing for familial hypercholesterolemia.
Miller AA; Bangash H; Smith CY; Wood-Wentz CM; Bailey KR; Kullo IJ
Genet Med; 2022 Dec; 24(12):2535-2543. PubMed ID: 36173399
[TBL] [Abstract][Full Text] [Related]
19. Predictive Modeling and Structure Analysis of Genetic Variants in Familial Hypercholesterolemia: Implications for Diagnosis and Protein Interaction Studies.
Larrea-Sebal A; Jebari-Benslaiman S; Galicia-Garcia U; Jose-Urteaga AS; Uribe KB; Benito-Vicente A; Martín C
Curr Atheroscler Rep; 2023 Nov; 25(11):839-859. PubMed ID: 37847331
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
